SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness

This alert advises on identification of patients who are at risk of developing (or already in early stages of) diabetic ketoacidosis, so that prompt corrective measures can be applied. Treatment may be restarted when ketone values are normal and patients’ condition has stabilised


Medicines and Healthcare products Regulatory Agency